Psychedelics and biopharma company
Mydecine (CSE:MYCO) (OTC:MYCOF) recently announced the successful export of 20 kilograms of dried psilocybin mushrooms from a cultivation facility in Jamaica to a facility in Canada.
A World’s First: According to the Denver-based company, this represents the first-ever legal international export of psilocybin mushrooms.
Mydecine was able to receive the shipment by the exercise of a Health Canada Schedule 1 Dealer’s License held by its Canadian facility, which permits the “import/export, research and development, cultivation, product development, and commercial sale of active psychedelic medicinal compounds.”
“We are now able to access a quality source of much needed product for both our own research purposes, as well as provide CGMP naturally-derived psilocybin to sell and transfer to other licensed research facilities around the globe,” Mydecine CEO and Chairman Joshua Bartch said in a prepared statement.
Breaking News: Mydecine Fully Completes the First-Ever International Export of Psilocybin Mushrooms and Solidifies its Clinical and Commercial Supply Chain | Breaking News: Mydecine Fully Completes the First-Ever International Export of Psilocybin Mushrooms and Solidifies its Clinical and Commercial Supply ChainFinancial Buzz
financialbuzz.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialbuzz.com Daily Mail and Mail on Sunday newspapers.
Cheers & Jeers
heraldstandard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from heraldstandard.com Daily Mail and Mail on Sunday newspapers.